FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 4 filers reported holding FATE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $236,791 | +40.3% | 110,392 | +212.3% | 0.00% | – |
| Q2 2023 | $168,811 | -29.7% | 35,353 | -16.6% | 0.00% | – |
| Q1 2023 | $240,241 | -45.2% | 42,408 | -3.2% | 0.00% | -100.0% |
| Q4 2022 | $438,420 | -24.1% | 43,798 | +74.5% | 0.00% | 0.0% |
| Q3 2022 | $578,000 | +124.0% | 25,097 | +139.6% | 0.00% | – |
| Q2 2022 | $258,000 | -22.1% | 10,474 | +25.6% | 0.00% | – |
| Q1 2022 | $331,000 | -10.1% | 8,341 | +97.5% | 0.00% | – |
| Q2 2021 | $368,000 | -26.7% | 4,223 | -65.9% | 0.00% | -100.0% |
| Q3 2020 | $502,000 | -7.7% | 12,391 | -21.8% | 0.00% | 0.0% |
| Q2 2020 | $544,000 | +133.5% | 15,852 | +54.2% | 0.00% | 0.0% |
| Q1 2020 | $233,000 | – | 10,279 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 716,392 | $11,126,000 | 12.18% |
| Polaris Venture Management Co. V, L.L.C. | 1,139,783 | $17,701,000 | 10.06% |
| Grosvenor Holdings, L.L.C. | 2,285,714 | $35,497,000 | 6.41% |
| Redmile Group, LLC | 11,216,809 | $174,197,000 | 5.83% |
| Casdin Capital, LLC | 2,550,000 | $39,601,500,000 | 4.10% |
| DAFNA Capital Management LLC | 470,000 | $7,299,000 | 2.74% |
| Ghost Tree Capital, LLC | 350,000 | $5,436,000 | 1.38% |
| Artal Group S.A. | 2,000,000 | $31,060,000 | 1.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,952,897 | $30,328,000 | 1.24% |
| Copernicus Capital Management, LLC | 75,000 | $1,165,000 | 1.08% |